Results 21 to 30 of about 83,610 (366)

Some clinical aspects of rheumatoid arthritis [PDF]

open access: yes, 1959
In our department we have been placing a special emphasis on the treatment and study of rheumatoid arthritis, and during the last four years we have handled about 1,600 cases visiting our outpatient clinic and approximately 100 hospitalized cases.
Kodama, Toshio
core   +1 more source

Treatment of calcifying epithelial odontogenic tumor/Pindborg tumor by a conservative surgical method

open access: yesJournal of Pharmacy and Bioallied Sciences, 2015
Calcifying epithelial odontogenic tumor (CEOT) also known as Pindborg tumor is a rare odontogenic epithelial neoplasm. So far nearly 200 cases have been reported in literature.
T Vigneswaran, R Naveena
doaj   +1 more source

Central giant cell granuloma in a child: Surgical intervention by maintaining tooth germ : A case report

open access: yesSaudi Journal of Oral Sciences, 2021
An intraosseous lesion of jaws called central giant cell granuloma (CGCG), is significantly found in children and young adults and most of the cases are nonaggressive, asymptomatic, and slow growing.
Nisha Kumari   +3 more
doaj   +1 more source

Denosumab May Increase the Risk of Local Recurrence in Patients with Giant-Cell Tumor of Bone Treated with Curettage

open access: yesJournal of Bone and Joint Surgery. American volume, 2018
Background: Recent clinical studies have suggested that denosumab is associated with tumor response and reduced surgical morbidity in patients with giant-cell tumor of bone (GCTB).
C. Errani   +6 more
semanticscholar   +1 more source

Nasal Lipopolysaccharide Challenge and Cytokine Measurement Reflects Innate Mucosal Immune Responsiveness [PDF]

open access: yes, 2015
BackgroundPractical methods of monitoring innate immune mucosal responsiveness are lacking. Lipopolysaccharide (LPS) is a component of the cell wall of Gram negative bacteria and a potent activator of Toll-like receptor (TLR)-4.
Dhariwal, J   +12 more
core   +3 more sources

Is Treatment with Denosumab Associated with Local Recurrence in Patients with Giant Cell Tumor of Bone Treated with Curettage? A Systematic Review.

open access: yesClinical Orthopaedics and Related Research, 2019
BACKGROUND Denosumab, a monoclonal antibody that binds to receptor activation of nuclear factor-kappa ß ligand (RANKL), has been used as a drug to treat aggressive giant cell tumors of bone.
S. Tsukamoto   +5 more
semanticscholar   +1 more source

Benign cementoblastoma of posterior mandible in growing patient

open access: yesSaudi Journal of Oral Sciences, 2022
Cementoblastoma is a benign tumor of odontoblastic origin usually associated with pain and swelling and mainly occurs in the mandibular region. It is mainly associated with the roots of premolars and molars in the second and third decades of life.
Santoshni Samal, Diljith Rishi
doaj   +1 more source

Odontogenic Myxoma Of The Maxilla: A Clinical Case Report And Review Of Literature [PDF]

open access: yes, 2013
Odontogenic myxomas are rare benign mesenchymal  tumours of head and neck with a potential for  local infiltration and recurrence. They appear to originate from the dental papilla, follicle or periodontal ligament in mandible and less commonly the ...
Bhardwaj, Vikram   +3 more
core   +2 more sources

Uterine Perforation with Omental Prolapse in a Case of Unsafe Abortion

open access: yesAsian Journal of Medical Sciences, 2012
We report a rare case of prolapsed omentum presenting as mass per vagina in a 24 year old unmarried female following dilatation and curettage for termination of pregnancy by unqualified physician.
Parinitha S Sangam
doaj   +1 more source

Seton Application in Complex Perianal Fistula: Video Presentation

open access: yesTurkish Journal of Colorectal Disease, 2021
Anal fistulas are non-physiological tract-like structures that open into the perianal skin starting from the distal rectum or anal canal and arise from abscesses on the basis of infection in the rudimentary glands around the dentate line.
Ahmet Topçu   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy